# Genotype-Driven Treatment of Advanced Non-small Cell Lung Cancer Based on mRNA Expression of ERCC1 & RRM1 as First-line Chemotherapy

> **NCT01648517** · PHASE2 · COMPLETED · sponsor: **Yonsei University** · enrollment: 60 (actual)

## Conditions studied

- Non-small Cell Lung Carcinoma

## Interventions

- **DRUG:** chemotherapy
- **DRUG:** chemotherapy

## Key facts

- **NCT ID:** NCT01648517
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07-27
- **Primary completion:** 2015-06-30
- **Final completion:** 2015-06-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01648517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01648517, "Genotype-Driven Treatment of Advanced Non-small Cell Lung Cancer Based on mRNA Expression of ERCC1 & RRM1 as First-line Chemotherapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01648517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*